humanitarian
Archived signal Translated · Português · 2–5m lag
Medicinas humanas Relatório Público Europeu de Avaliação (EPAR): Ruxolitinib Krka, ruxolitinib, Estado: Parecer
Medicinas humanas Relatório Público Europeu de Avaliação (EPAR): Phesgo, pertuzumab,trastuzomab, Data de autorização: 21/12/2020, Revisão: 8, Estado: Autorizado
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewMedicinas humanas Relatório Público Europeu de Avaliação (EPAR): Ruxolitinib Krka, ruxolitinib, Estado: ParecerEMA What Is NewHuman medicines European public assessment report (EPAR): Donrafylix, insulin aspart, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Fondaparinux Sodium Evumed, fondaparinux sodium, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Baxfendy, baxdrostat, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Garzulys, insulin aspart, Status: OpinionEMA What Is NewMedicamentos para Homem Relatório Público Europeu de Avaliação (EPAR): KemSu, sufentanil, cetamina, Estado: RejeitadoEMA What Is NewHuman medicines European public assessment report (EPAR): Meplyffa, arimoclomol, Status: RefusedEMA What Is NewMedicinas humanas Relatório Público Europeu de Avaliação (EPAR): Ruxolitinib Krka, ruxolitinib, Estado: ParecerEMA What Is NewHuman medicines European public assessment report (EPAR): Donrafylix, insulin aspart, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Zybrivo, sintilimab, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Fondaparinux sodium Evumed, fondaparinux sodium, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Amlypave, anselamimab, Status: Application withdrawn5 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources